Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Obesity Drugs Won't Starve These Other Potential Blockbusters
Stocks of developers of fatty liver disease treatments had been on a tear until results from Eli Lilly’s medication were published last week. Source link
Mallinckrodt in Talks to Cut Opioid Settlement by Up to $1 Billion
Mallinckrodt, the financially troubled pharmaceutical company, is in discussions with a compensation trust for opioid victims as it seeks to potentially reduce the amount of
FDA Approves Leqembi, Extending Alzheimer's Treatment to More Patients
Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval. Source link
Kidney-Care Specialist Diaverum Expected to Be Sold in $2 Billion Deal
Mubadala-backed M42 would buy the operator of 440 dialysis clinics from buyout firm Bridgepoint. Source link
Top Stocks To Buy Now? 3 Healthcare Stocks To Know
The healthcare industry, which is responsible for the development, manufacture, and distribution of medical products and services, is a critical sector of the economy. Healthcare
Johnson & Johnson Posts Higher Quarterly Sales, Raises 2023 Outlook
First-quarter earnings were largely wiped out by a $6.9 billion charge tied to litigation and other costs from its Covid-19 vaccine commitments. Source link
Demand for Obesity Drugs Has Insurers Paying Close Attention
Markets Heard on the Street Strong sales of obesity-diabetes drugs known as GLP-1s could affect insurance companies’ financial results Source link
Moderna, Merck Show Progress Toward Cancer Vaccines
An mRNA shot helped prevent relapse in high-risk melanoma patients. Source link
WeightWatchers Gets a Makeover With Obesity-Drug Business
Markets Heard on the Street The decision to get into the business for drugs such as Ozempic makes sense Source link
Merck in Late-Stage Talks to Acquire Prometheus Biosciences
Merck & Co. is in late-stage talks to acquire Prometheus Biosciences Inc., according to people familiar with the matter, a move that could give the